Your search returned 11 studies:
- Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Conditions: Multiple Sclerosis
Location: Worcester, Massachusetts
- Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Conditions: Multiple Sclerosis
Location: Milford, Massachusetts
- Genes and Environment in Multiple Sclerosis
Conditions: Multiple Sclerosis
Location: Boston, Massachusetts
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Conditions: Pediatric Multiple Sclerosis
Location: Boston, Massachusetts
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Conditions: Pediatric Multiple Sclerosis
Location: Boston, Massachusetts
- A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting
Location: Boston, Massachusetts
- A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting
Location: Providence, Rhode Island
- Pregnancy Registry Trial
Conditions: Multiple Sclerosis
Location: Cambridge, Massachusetts
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Conditions: Central Neuropathic Pain - Multiple Sclerosis
Location: Boston, Massachusetts
- Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Conditions: Multiple Sclerosis
Location: Boston, Massachusetts
- Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Conditions: Autoimmune Diseases of the Nervous System - Multiple Sclerosis - Secondary Progressive Multiple Sclerosis - Disease Progression - Brain Atrophy
Location: Boston, Massachusetts
|